Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice
Ghasem Ghalamfarsa(Yasuj University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Fatemeh Atyabi(Tehran University of Medical Sciences), Enayat Anvari(Medical University of Ilam), Ali Rastegari(Tehran University of Medical Sciences), Bahman Yousefi(Semnan University of Medical Sciences), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Amir Ghanbari(Yasuj University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Hadi Hassannia(Mazandaran University of Medical Sciences), Jamshid Hadjati(Aja University of Medical Sciences), Jamshid Mohammadi(Yasuj University of Medical Sciences), Ali Masjedi(Tabriz University of Medical Sciences)
Cited by 75
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312